Our demonstration that CIP2A and Oct4 expression is linked to poor differentiation level of HNSCC tumors, and predicts for a poor patient survival among HNSCC patients treated with radiotherapy is intriguing. This evidence concerns the gene POU5F1 and head and neck squamous cell carcinoma.